销售和管理费用 更改
Adidas EUR 2.68B 283M 2026-03
Adyen EUR 156.16M 14.47M 2025-12
Akzo Nobel EUR 804M 7M 2026-03
Alcon AG USD 882M 19M 2026-03
Amadeus IT EUR 497.5M 206.6M 2025-03
Amarin USD 18.97M 1.03M 2025-12
AstraZeneca USD 5.06B 455M 2026-03
BASF EUR 2.13B 84M 2026-03
Bayer EUR 3.7B 356M 2026-03
Beiersdorf EUR 271M 51M 2025-12
Covestro EUR 445M 8M 2025-12
Danone EUR 4.7B 170M 2025-12
Fresenius EUR 819M 143M 2025-12
Fresenius Medical Care EUR 749M 36M 2026-03
Genmab DKK 208M 60M 2025-12
Givaudan CHF 561M 25M 2025-12
GlaxoSmithKline GBP 2.12B 558M 2026-03
GRIFOLS EUR 281M 5.7M 2026-03
Henkel EUR 3.49B 38M 2025-12
Hikma Pharmaceutical USD 288M 149M 2025-12
Infineon EUR 379M 30M 2026-03
Lakefront Biotherapeutics EUR 35.5M 8.91M 2026-03
Linde USD 880M 40M 2025-12
Merck EUR 1.52B 80M 2026-03
Novartis USD 3.14B 296M 2026-03
Philips EUR 1.18B 121M 2026-03
Roche Holding CHF 7.28B 3.99B 2025-12
Sanofi EUR 2.33B 419M 2026-03
UCB EUR 1.47B 193M 2025-12